Multiple myeloma is a type of cancer that affects the bone marrow and plasma cells. It is a form of cancer that affects a type of white blood cell called a plasma cell. Plasma cells are a type of immune cell that helps to fight infection and disease. In multiple myeloma, a group of abnormal plasma cells called myeloma cells grow uncontrollably in the bone marrow and interfere with the production of healthy blood cells.
The exact cause of multiple myeloma is unknown. However, it is believed to be linked to changes in the DNA of the myeloma cells. These changes can occur due to environmental or genetic factors.
The signs and symptoms of multiple myeloma can vary from person to person. Common signs and symptoms include:
1. Fatigue
2. Bone pain
3. Unexplained weight loss
4. Increased risk of infection
5. Anemia (low red blood cell count)
6. Easy bleeding or bruising
Depending on the severity of the condition, treatment for multiple myeloma may include:
1. Chemotherapy: Chemotherapy is used to destroy the cancer cells.
2.Radiotherapy: This type of treatment uses high-energy X-rays to destroy cancer cells.
3. Stem cell transplant: This procedure involves replacing the damaged bone marrow with healthy cells.
4. Targeted therapy: This type of therapy uses drugs to target specific cancer cells.
In some cases, surgery may be recommended to remove tumors or affected areas of bone.
Living with multiple myeloma can be difficult. It is important to seek support from family and friends as well as from healthcare professionals. It is also important to stay informed about the latest treatments and research related to the condition.
Bortenat 3.5mg Injection consists of the active substance Bortezomib. It is a chemotherapy medication indicated for the treatment of multiple myeloma and mantle cell lymphoma. Multiple myeloma refers to cancerous progression of plasma cells that are predominant in the bone marrow. Mantle cell lymphoma is a less common type of cancer that affects the lymph nodes.